Log in

Relevant bibliographies by topics / Cardiovascular and metabolic disease / Books

To see the other types of publications on this topic, follow the link: Cardiovascular and metabolic disease.

Books on the topic 'Cardiovascular and metabolic disease'

Author: Grafiati

Published: 4 June 2021

Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Cardiovascular and metabolic disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Peplow, Philip, James Adams, and Tim Young, eds. Cardiovascular and Metabolic Disease. Cambridge: Royal Society of Chemistry, 2015. http://dx.doi.org/10.1039/9781782622390.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Metabolic syndrome and cardiovascular disease. Philadelphia, PA: Saunders/Elsevier, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Levine, T. Barry. Metabolic syndrome and cardiovascular disease. Philadelphia, PA: Saunders, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Association, American Heart, ed. Metabolic risk for cardiovascular disease. Dallas, TX: American Heart Association, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Levine, T. Barry. Metabolic syndrome and cardiovascular disease. 2nd ed. Chichester, West Sussex: Wiley-Blackwell, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Levine, T. Barry, and Arlene B. Levine. Metabolic Syndrome and Cardiovascular Disease. Oxford, UK: Blackwell Publishing Ltd., 2012. http://dx.doi.org/10.1002/9781118480045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Levine, T. Barry. Metabolic syndrome and cardiovascular disease. 2nd ed. Chichester, West Sussex: Wiley-Blackwell, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Nutritional and metabolic bases of cardiovascular disease. Chichester, West Sussex: Wiley-Blackwell, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mancini, Mario, José M. Ordovas, Gabriele Riccardi, Paolo Rubba, and Pasquale Strazzullo, eds. Nutritional and Metabolic Bases of Cardiovascular Disease. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444318456.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

1933-, Simopoulos Artemis P., ed. Nutrition and fitness: Obesity, the metabolic syndrome, cardiovascular disease, and cancer. Basel: Karger, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Granata, Riccarda, and Jørgen Isgaard. Cardiovascular issues in endocrinology. Basel: Karger, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Jiang, Xian-Cheng, ed. Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-6082-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Marín-García, José. Mitochondria and their role in cardiovascular disease. New York: Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Obstructive sleep apnea in adults: Relationship with cardiovascular and metabolic disorders. Basel: Karger, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

International Meeting on Atherosclerosis and Cardiovascular Diseases. (7th 1989 Bologna, Italy). Atherosclerosis and cardiovascular disease: 7° international meeting, Bologna, September 1989. Edited by Descovich G. C. Bologna: Editrice Compositori, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cholesterol: Interactions with testosterone and cortisol in cardiovascular diseases. Berlin: Springer-Verlag, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

J, Halpern M., ed. Lipid metabolism and its pathology. New York: Plenum Press, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

J, Pownall Henry, ed. Manual of lipid disorders: Reducing the risk for coronary heart disease. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

J, Pownall Henry, ed. Manual of lipid disorders: Reducing the risk of coronary heart disease. 2nd ed. Baltimore: Williams & Wilkins, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

E, Beamish Robert, Panagia Vincenzo, Dhalla Naranjan S, University of Manitoba, and Cardiology Symposium (3rd : 1986 : Winnipeg, Man.), eds. Pharmacological aspects of heart disease: Proceedings of an International Symposium on Heart Metabolism in Health and Disease and the Third Annual Cardiology Symposium of the University of Manitoba, July 8-11, 1986, Winnipeg, Canada. Boston: Nijhoff, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

L, Hess Michael, ed. Free radicals, cardiovascular dysfunction, and protection strategies. Austin: R.G. Landes Co., 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Statusseminar in the Framework of the German-Israeli Cooperation in Medical Research (2nd 1989 Reisenburg, Germany). Preventive cardiology: Diagnostic and metabolic aspects of cardiovascular research : selected papers presented at the 2nd Statusseminar in the Framework of the German-Israeli Cooperation in Medical Research, Reisenburg, 22-23 May 1989. München: Urban & Schwarzenberg, 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

J, Halpern M., ed. Lipid metabolism and its pathology: Proceedings of the IVth International Colloquium on Lipid Metabolism and its Pathology, Lisbon, 18-22 November 1984. Amsterdam: Excerpta Medica, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Gotto, Antonio M. Manual of lipid disorders. Baltimore: Williams & Wilkins, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Maria, Cancela Carral Jose, and Varela Martinez Silvia, eds. Aerobic exercise in special populations. Hauppauge, N.Y: Nova Science, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Levine, T. Barry, and Arlene Bradley Levine. Metabolic Syndrome and Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Levine, T. Barry, and Arlene Bradley Levine. Metabolic Syndrome and Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Eckel, Robert H. Metabolic Risk for Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Eckel, Robert H. Metabolic Risk for Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Krentz, Andrew J., and Nathan D. Wong, eds. Metabolic Syndrome and Cardiovascular Disease. CRC Press, 2006. http://dx.doi.org/10.3109/9781420020601.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Metabolic Syndrome and Cardiovascular Disease. Elsevier, 2006. http://dx.doi.org/10.1016/b978-1-4160-2545-0.x5001-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Eckel, Robert H. Metabolic Risk for Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Mancini, Mario, Jose M. Ordovas, Gabrielle Riccardi, Paolo Rubba, and Pasquale Strazzullo. Nutritional and Metabolic Bases of Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Mancini, Mario, Jose M. Ordovas, Gabrielle Riccardi, Paolo Rubba, and Pasquale Strazzullo. Nutritional and Metabolic Bases of Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Mancini, Mario, Jose M. Ordovas, Gabrielle Riccardi, Paolo Rubba, and Pasquale Strazzullo. Nutritional and Metabolic Bases of Cardiovascular Disease. Wiley & Sons, Incorporated, John, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

(Editor), Andrew Krentz, and Nathan Wong (Editor), eds. Metabolic Syndrome and Cardiovascular Disease: Epidemiology, Assessment, and Management. Informa Healthcare, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Metabolic syndrome and cardiovascular disease: Epidemiology, assessment, and management. New York, NY: Informa Healthcare, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

J, Krentz Andrew, and Wong Nathan D, eds. Metabolic syndrome and cardiovascular disease: Epidemiology, assessment, and management. New York: Informa Healthcare, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

39

Adams, James, Tim Young, Diler Aslan, and Shahrad Taheri. Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies. Royal Society of Chemistry, The, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

(Editor), Andrew Krentz, and Nathan Wong (Editor), eds. Metabolic Syndrome and Cardiovascular Disease: Epidemiology, Assessment, and Management. Informa Healthcare, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

M, Forte Trudy, ed. Hormonal, metabolic, and cellular influences on cardiovascular disease in women. Armonk, NY: Futura Pub., 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Pereira, Luis F., Harold W. Goforth, Esteban Martínez, Joseph Z. Lux, Maria Ferrara, and Michael P. Mullen. Cardiovascular Disease, Metabolic Complications and Lipodystrophy in Persons with HIV. Edited by Mary Ann Cohen, Jack M. Gorman, Jeffrey M. Jacobson, Paul Volberding, and Scott Letendre. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199392742.003.0046.

Full text

Abstract:

The introduction of effective antiretroviral therapy has contributed to a dramatic reduction in HIV-related mortality. As patients live longer, evidence suggests an increased incidence of cardiovascular disease in persons with HIV over that among individuals who do not have HIV, thus early detection and treatment of multimorbidities and modifiable cardiovascular disease risk factors particularly in persons with HIV are needed. Several mechanisms have been proposed to explain the increased risk of cardiovascular disease, including the virus itself, antiretroviral therapy, and traditional risks factors. This chapter discusses detection and treatment of cardiovascular disease in persons with HIV, as well as metabolic complications involved, including dyslipidemia, insulin resistance, and lactic acidosis. The pathogenesis and management of HIV-associated lipodystrophy as well as its psychosocial impact are also addressed.

APA, Harvard, Vancouver, ISO, and other styles

43

The cardiovascular and metabolic responses of men with cardiovascular disease to aqua dynamic exercise. 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

The cardiovascular and metabolic responses of men with cardiovascular disease to aqua dynamic exercise. 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

(Editor), Ezra A. Amsterdam, Denise D., M.d. Barnard (Editor), Barry H. Greenberg (Editor), Scott M. Grundy (Editor), and Philip M., M.d. Liebson (Editor), eds. Contemporary Cardiovascular Continuum. Handbooks in Health Care Company, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Simopoulos, A. P., ed. Nutrition and Fitness: Obesity, the Metabolic Syndrome, Cardiovascular Disease, and Cancer. S. Karger AG, 2005. http://dx.doi.org/10.1159/isbn.978-3-318-01228-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Z, Fisman Enrique, and Tenenbaum Alexander, eds. Cardiovascular diabetology: Clinical, metabolic and inflammatory facets. Basel: Karger, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Z, Fisman Enrique, and Tenenbaum Alexander, eds. Cardiovascular diabetology: Clinical, metabolic and inflammatory facets. Basel: Karger, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Elder, Grahame J. Metabolic bone disease after renal transplantation. Edited by Jeremy R. Chapman. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0288.

Full text

Abstract:

Patients who undergo kidney transplantation have laboratory, bone, and soft tissue abnormalities that characterize chronic kidney disease mineral and bone disorder (CKD-MBD). After successful transplantation, abnormal values of parathyroid hormone, fibroblast growth factor 23, calcium, phosphate, vitamin D sterols, and sex hormones generally improve, but abnormalities often persist. Cardiovascular risk remains high and is influenced by prevalent vascular calcification, and fracture risk increases due to a combination of abnormal bone ‘quality’, compounded by immunosuppressive drugs and reductions in bone mineral density. Patients with well managed CKD-MBD before transplantation generally have a smoother post-transplant course, and it is useful to assess patients soon after transplantation for risk factors relevant to the general population and to patients with CKD. Targeted laboratory assessment, bone densitometry, and X-ray of the spine are useful for guiding therapy to minimize post-transplant effects of CKD-MBD. To reduce fracture risk, general measures include glucocorticoid dose minimization, attaining adequate 25(OH)D levels, and maintaining calcium and phosphate values in the normal range. Calcitriol or its analogues and antiresorptive agents such as bisphosphonates may protect bone from glucocorticoid effects and ongoing hyperparathyroidism, but the efficacy of these therapies to reduce fractures is unproven. Alternate therapies with fewer data include denosumab, strontium ranelate, teriparatide, oestrogen or testosterone hormone replacement therapy, tibolone, selective oestrogen receptor modulators, and cinacalcet. Parathyroidectomy may be necessary, but is generally avoided within the first post-transplant year. A schema is presented in this chapter that aims to minimize harm when allocating therapy.

APA, Harvard, Vancouver, ISO, and other styles

50

(Editor), E. Z. Fisman, and A. Tenenbaum (Editor), eds. Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets (Advances in Cardiology). S Karger Pub, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!